Categories AlphaGraphs, Earnings, Other Industries

Retail pharmacy lifts CVS Health in the first quarter

CVS Health Corporation (CVS) reported an increase of 2.6% in revenues to around $45.7 billion for the first quarter of 2018 compared to the prior year period. Net income rose 4.7% to $998 million or $0.98 per share. Adjusted EPS came in at $1.48, beating market estimates. CVS shares rose over 2% in premarket trade following the earnings release.

The quarterly results benefited from higher prescription volumes within the retail pharmacy business and a lower income tax rate.

In the Pharmacy Services segment, revenues grew 3.2% to about $32.2 billion, primarily driven by growth in pharmacy network and specialty claim volume as well as brand inflation. Pharmacy network claims processed during the quarter increased 6%. In the Retail/LTC segment, revenues rose 5.6% to about $20.4 billion, driven primarily by an increase in the same-store prescription volume of 8.5%.

Same-store sales increased 5.8% while pharmacy same-store sales grew 7.3% during the quarter. Front store same-store sales improved 1.6% in the quarter. The increase in pharmacy same-store sales was mainly driven by the rise in the pharmacy same-store prescription volumes, partially offset by a negative impact of approximately 280 basis points due to recent generic introductions.

CVS Health Q1 2018 Earnings Infographic
CVS Health Q1 2018 Earnings Infographic

 

CVS expects GAAP diluted EPS between $5.11 and $5.32, and adjusted EPS between $6.87 and $7.08 for the full year of 2018. For the second quarter of 2018, the company expects GAAP diluted EPS of $1.21-$1.26 and adjusted EPS of $1.59-$1.64.

Shareholders of both companies approved the proposed acquisition of Aetna by CVS Health on March 13, 2018. The regulatory approval process is proceeding as per expectations. The transaction is expected to close during the second half of 2018. Aetna reported its earnings on Tuesday where its adjusted EPS of $3.19 beat analyst estimates.

During the first quarter, CVS launched the Rx Savings Finder initiative to tackle rising drug prices. This initiative has helped to improve transparency and reduce costs for customers.

Most Popular

Earnings calendar for the week of March 8

On the heels of lawmakers moving closer to passing the stimulus bill, inflations concerns gripped the market after Federal Reserve chief Jerome Powell at a meeting said the reopening would

Why Costco’s (COST) growth prospects might depend on beating costs, digital lag

Though the retail boom triggered by the pandemic was estimated to be short-lived initially, the shopping spree continued as customers stocked up on essential items, concerned about the persistent market

Gap (GPS) hopes to see a favorable recovery by the second half of 2021

Shares of Gap Inc. (NYSE: GPS) were up 5.8% in afternoon hours on Friday. The stock has gained 103% over the past 12 months. Gap reported mixed results for the

Tags

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top